- October 12, 2021
The Probiota Asia Digital Summit brings together experts from the worlds of business and academia to expand knowledge and discuss about the challenges and opportunities of prebiotics, probiotics and microbiome modulation for better human health.
On-Line
OCTOBER 26 – NOVEMBER 3, 2021
Probiota Asia 2021 is FREE to attend
but pre-registration is required.
virtual event
Gnosis by Lesaffre is proud to partner with the #Probiota Asia 2021 Digital Summit! Join us this year to this on-line edition to explore our innovative probiotics and solutions dedicated to human health and microbiome modulation.
Taking place on 26 – 27 October and 2 – 3 November, the digital summit will showcase the last scientific and academic findings through high-level keynote presentations, engaging panel discussions and live Q&A to open the discussion on how to seize new business opportunities in Asia and Middle East.
Register now and join us to deep-dive together into the world’s fastest-growing region for probiotics and prebiotics
Partners will also have the possibility to schedule 1-1 meetings:
The team at Gnosis by Lesaffre & NutraIngredients-Asia look forward to seeing you there!
The unique yeast probiotic strain with clinically validated efficacy for acute diarrhea management in infant & children, and 5 years shelflife.
Stable probiotic which may support immunity.
A patented strain of Saccharomyces cerevisiae, a probiotic yeast that supports vaginal health and women’s vaginal microflora.
DISCOVER ALL OUR LATEST NEWS
Webinar: The stable probiotic for immunity in a new intestine-on-chip model
Register to the upcoming webinar: LifeinU™ BSCU1 in a new scientific model: intestine-on-chip on December 14, 2021 – 11:00 AM EDT
WEBINAR: The benefits of Quatrefolic®, the innovactive folate
Folate is one of the most common vitamin deficiencies, also because body requires the conversion of folic acid to its active form, methylfolate.
Unlocking the research on probiotics and immunity
To innovate in a better and more sustainable way, Gnosis by Lesaffre has developed, with a partner, a new dynamic model that mimics the human model in preclinical stages called the gut-on-chip model.
